Acetyl-CoA carboxylase (ACC) 1 is a key enzyme in fatty acid biosynthesis catalyzing the transfer of a carboxyl group to acetyl-CoA to form malonyl-CoA. Malonyl-CoA serves as the active donor of two carbon atoms in fatty acid synthesis and strongly inhibits fatty acid ␤-oxidation by acting as a potent inhibitor of carnitine palmitoyltransferase I (1, 2) . Carnitine palmitoyltransferase I resides on the surface of the mitochondrial membrane and generates palmitoylcarnitine from palmitoyl-CoA. This step is critical for fatty acid ␤-oxidation because cytosolic fatty acyl-CoA cannot translocate into the mitochondria where fatty acid ␤-oxidation occurs. Palmitoylcarnitine is transported into mitochondra by a carrier system and then reconverted into palmitoyl-CoA by carnitine palmitoyltransferase II. This shuttle system is the first step of fatty acid ␤-oxidation, which supplies tissues with energy.
Mammals have two major isoforms of acetyl-CoA carboxylase. The 265-kDa isoform, designated as ACC␣, is highly expressed in liver and adipose tissues, and the 280-kDa isoform, designated as ACC␤, is predominantly expressed in heart and skeletal muscle (3) (4) (5) . Human ACC␣ and ACC␤ have about 80% amino acid sequence homology and both produce malonylCoA. They are, however, encoded by separate genes, mapped to chromosome 17q21 and 12q23.1, respectively, and show distinct tissue distribution and nutritional regulation (6 -8) . The presence of the ␤-isoform in tissues that do not actively synthesize fatty acid de novo has not been clearly explained. It has been suggested that ACC␤ may play a role in mitochondrial fatty acid ␤-oxidation in muscle tissues. Its product malonylCoA might be a critical regulatory tool for mitochondrial fatty acid uptake and metabolism (9, 10) .
Compared with ACC␣, little is known about the regulation of ACC␤. To study the transcriptional regulation of ACC␤ we cloned the 17-kb human ACC␤ promoter and analyzed its ciselements and trans-acting factors. Transcriptional regulation of muscle-specific genes is commonly studied by investigating the effects of muscle-specific and stage-specific transcription factors (11) (12) (13) (14) . One of the sequence motifs characterized as a critical regulatory component in muscle gene expression is the E-box (CANNTG) (15) (16) (17) . Muscle-specific genes, such as muscle creatine kinase, myosin light chain, and myogenin genes, have multiple E-boxes in their enhancers or promoters that act cooperatively to regulate gene transcription (18 -20) . E-boxes are binding sites for ubiquitously expressed bHLH family pro- 82-2-312-5041; E-mail: kyungsup59@yumc.yonsei.ac.kr. 1 The abbreviations used are: ACC, acetyl-CoA carboxylase; MRF, muscle regulatory factor; bHLH, basic helix-loop-helix; 5Ј-UTR, 5Ј-untranslated region; EMSA, electrophoretic mobility shift assay; PCR, polymerase chain reaction; kb, kilobase pair(s); bp, base pair(s); PCR, polymerase chain reaction; RT-PCR, reverse transcriptase-polymerase chain reaction; PIPES, 1,4-piperazinediethanesulfonic acid.
teins, known as E-proteins. In muscle cells, E-proteins dimerize with muscle-related bHLH transcription factors, called muscle regulatory factors (MRFs), enabling the MRFs to act on muscle-specific regulatory elements (21, 22) . The four musclespecific MRFs, MyoD, myogenin, Myf5, and MRF4, have been characterized in terms of their significance in development through stage-specific utilization of those factors (23) (24) (25) .
Because there are several E-boxes on the ACC␤ promoter, we expected that the muscle-specific expression of ACC␤ might be explained by the responsiveness of its promoter to MRFs. In this study, we report the fact that ACC␤ is transcriptionally activated by MyoD through the E-boxes on its promoter. We also report a novel cis-acting element which serves as an MRFbinding site and is critically required for the MyoD-mediated ACC␤ promoter activation. Elaboration upon the transcriptional regulation of ACC␤ in the context of myogenesis-related factors might provide further understanding of the musclespecific expression of ACC␤.
MATERIALS AND METHODS
Cloning of ACC␤ Promoter-Previous isolation of the ACC␤ cDNA from a human skeletal muscle cDNA library (7) yielded two cDNA clones with different 5Ј-untranslated regions (5Ј-UTR) of 300 and 42 bp, respectively. 2 In the presence of the sense primer (5Ј-ATGTAACCCT-GAATGCACGGTGGGGAGGACAT-3Ј) of the 300 bp 5Ј-UTR and the antisense primer (5Ј-TCACTGGGGATGCAGCCACCAGCTCCATT-3Ј) of the 42-bp 5Ј-UTR, PCR using human genomic DNA as a template produced a 14.5-kb DNA fragment spanning these two 5Ј-UTRs. The PCR reaction was performed using Expand TM Long Template PCR system (Roche Molecular Biochemicals). The PCR was set at 94°C for 10 s for denaturation, at 60°C for 30 s for annealing, and at 68°C for 8 min for extension and repeated for 30 cycles. After the final cycle, the elongation was carried out at 68°C for 7 min. The amplified DNA fragment was subcloned into pGEM4Z (Promega) and its restriction map was determined (Fig. 1A) . The 5Ј-flanking region of the 300-bp 5Ј-UTR was obtained by inverse PCR. Ten g of human genomic DNA was digested with 50 units of EcoRI and followed by phenol/chloroform extraction and ethanol precipitation. The precipitated DNA was selfligated in the volume of 1 ml using T4 DNA ligase (100 units) at 16°C for 14 h. Self-ligated DNA was precipitated by ethanol after phenol/ chloroform extraction, and was dissolved in 20 l of TE buffer (pH 8.0). The flanking sequence of 300 bp 5Ј-UTR was amplified by PCR using 5Ј antisense primer (5Ј-CCTGGAGCACTTAACCTTAACCTTCA-3Ј), and 3Ј sense primer (5Ј-TAAGCAGCAAGCAGGCTTAG-3Ј), and 0.5 g of self-ligated DNA. The amplified DNA was subcloned into pGEM4Z and sequenced.
Primer Extension-An oligonucleotide (5Ј-CAGGAAAAGGTCAGA-CAGACAGGA-3Ј), complementary to the region ϩ37 to ϩ56 from the ATG codon of ACC␤ was labeled with [␥-32 P]ATP by polynucleotide kinase. The labeled oligonucleotide (10 5 cpm) was mixed with 1 g of human skeletal muscle poly(A) ϩ RNA (CLONTECH) in 10 l of 25 mM PIPES (pH 6.8), 400 mM NaCl, 1 mM EDTA. The mixture was incubated at 70°C for 3 min, then slowly cooled down to 37°C and incubated overnight at 37°C. Annealed primer/RNA was precipitated by adding 25 l of ethanol and used for extension reaction. This primer was extended with 200 units of SuperScript II reverse transcriptase (Life Technologies, Inc.) at 42°C for 1 h under the buffer conditions the manufacturer recommended. After phenol/chloroform (1:1, v/v) extraction and ethanol precipitation, the size of primer extension product was determined by 8% denaturing polyacrylamide gel electrophoresis. The nucleotide numbering of the ACC␤ promoter was based on the transcription start site proved by primer extension analysis. To confirm that the primer extension product contains the 5Ј-UTR of the ACC␤ cDNA, the primer extension product was isolated from the denaturing polyacrylamide gel and used as a template in following PCR. Primers used in the PCR were the 5Ј sense primer corresponding to the region Ϫ72 to Ϫ53, or Ϫ55 to Ϫ34 from the ATG codon and the 3Ј antisense primer used in primer extension analysis. The size of the PCR products was determined on an 8% native polyacrylamide gel.
RT-PCR-Total RNAs were extracted from Alexander cells, HepG2 cells, and human skeletal muscle, using the TRIzol (Life Technologies, Inc.) according to the manufacturer's instructions. First-strand cDNAs were synthesized from 2 g of total RNA in 20 l of reaction volume using SuperScript II reverse transcriptase (Life Technologies, Inc.). Each reverse transcription mixture (0.5 l) was used as the template for amplifying ACC␤ cDNA. The PCR primers for the 5Ј terminal region of ACC␤ transcript, spanning exon 1b and exon 2, were the sense primer corresponding to the region Ϫ72 to Ϫ53 from the ATG codon and the antisense primer same as that used in the primer extension analysis. The ACC␤ cDNA corresponding to the region ϩ6001 to ϩ7000 from the ATG codon and glyceraldehyde-3-phosphate dehydrogenase cDNA were amplified using following primers: ACC␤ sense, 5Ј-TCCAACAAC-CAGCTGGGTGGCGTTC-3Ј; ACC␤ antisense, 5Ј-CCAGCATCCGGC-CGGGTGTGTCATG-3Ј; glyceraldehyde-3-phosphate dehydrogenase sense, 5Ј-ACCACAGTCCATGCCATCAC-3Ј; and glyceraldehyde-3-phosphate dehydrogenase antisense, 5Ј-GGAGACCTTCTGCTCAGTC-GACG-3Ј. The sizes of the PCR products were determined on an 8% native polyacrylamide gel or on 1.0% agarose gels.
Construction of Transfection Plasmids-The PII␤ promoter-reporter construct of pPII␤Ϫ1317 was generated by subcloning the 3Ј 1.4-kb XbaI fragment (Ϫ1317 to ϩ65) of the 14.5-kb PCR product into SmaI site of pGL3-Basic (Promega). The constructs designated as pPII␤Ϫ1090, pPII␤Ϫ569, pPII␤Ϫ349, and pPII␤Ϫ203 were produced by self-ligation of pPII␤Ϫ1317 after digestion with KpnI, KpnI/ApaI, KpnI/DraI, and KpnI/HindIII, respectively. The constructs of pPII␤Ϫ800, pPII␤Ϫ93, pPII␤Ϫ38, and pPII␤ϩ7 were generated by insertion of the DNA fragments amplified by PCR into SmaI site of pGL3-Basic. The construct of pPII␤Ϫ1317/ϩ17 was produced by ligation of the 4.5-kb NarI-flushed/XbaI fragment of pPII␤-1317 and 1.7-kb SmaI/XbaI luciferase gene of pGL3-Basic. The construct, pPII␤Ϫ1317/ϩ3 was prepared by subcloning the DNA fragment from Ϫ1317 to ϩ3 of PII␤ amplified by PCR into SmaI site of pGL3-Basic. Mutant constructs were generated employing QuikChange TM site-directed mutagenesis kit (Stratagen) using the mutagenic oligonucleotides. Every mutated sequence is explained in the legends to Figs. 5 and 6, and the sequences of all mutant constructs were confirmed by DNA sequencing. The construction of the pE-box-tk-luc and the p6ϫ(ϩ8/ ϩ27)-tk-luc was performed by inserting Ϫ569 to Ϫ204 of PII␤ and six copies of the fragment from ϩ8 to ϩ27 of PII␤, respectively, into the upstream of the tk promoter of ptk-luc, a tk-promoter-luciferase reporter construct.
Cell Culture and Transient Transfection Assay-The established cell lines, obtained from American Type Culture Collection (Rockville, MD), were cultured in the recommended media (H9C2 in DMEM/F12; Alexander in MEM; HeLa in MEM; NIH3T3 in Dulbecco's modified Eagle's medium) supplemented with 10% fetal calf serum, 100 units/ml penicillin G sodium, 100 g/ml streptomycin sulfate at 37°C under 5% CO 2 , 95% air. All cell culture materials were purchased from Life Technologies, Inc. For the transient transfection assay, cells were plated at a density of 2 ϫ 10 5 cells/35-mm dish. On the next day, transfection was performed with 0.4 g of the indicated pPII␤-luciferase constructs, 0.2 g of the pCMV ␤-galactosidase plasmid (CLONTECH) and the indicated amounts of pcDNA3 (Invitrogen), pcMyoD, or pcE12. The pcMyoD and pcE12 plasmids were kindly provided by Stephan F. Konieczny (Purdue University) and express MyoD and E12, respectively, under the control of the cytomegalovirus IE promoter. Transfection was performed using LipofectAMINE Plus transfection reagent (Life Technologies, Inc.) for 3 h according to the manufacturer's instructions. After 2 days, cells were washed with phosphate-buffered saline (Life Technologies, Inc.) and lysed in 200 l of reporter lysis buffer (Promega). Luciferase activities were measured using the Luciferase Assay System (Promega) and normalized by the ␤-galactosidase activities to correct for the transfection efficiency. All plasmid DNA for transfections was purified by Qiagen Plasmid Midi kit (Qiagen Inc.)
Yeast One-hybrid Screening-A human skeletal muscle cDNA library was screened employing the Matchmaker one-hybrid system (CLON-TECH). All procedures were performed according to the manufacturer's instructions. For the construction of a target-reporter yeast strain, 3 copies of the 20-bp fragment corresponding to nucleotides from Ϫ42/ Ϫ23, Ϫ10/ϩ10, and ϩ8/ϩ27 was inserted into the SacI site of pHisi-1 and pLacZi. The resulting plasmids were linearized and transformed into Saccharomyces cerevisiae strain YM4271 by the lithium acetate method, and the transformants were selected on SD-His,Ura solid medium for integration of the target-reporter construct into the HIS3 locus. To screen the clones expressing the proteins that bind to the target sequences in vivo, a human skeletal muscle cDNA library constructed in pGAD10 was introduced into the above transformed YM4271. pGAD10, the expression vector of the Matchmaker yeast two-hybrid system produces the inserted gene product as a C terminus of GAL4 activation domain-fusion protein. Clones were selected on SD-His,Ura,Leu solid medium containing 40 mM 3-amino-1,2,4-triazole (Sigma). Plasmids isolated from the selected yeast clones were transformed into the Escherichia coli strain DH5␣ and subjected to sequencing for identification.
Preparation of Recombinant MyoD, E47, Myf4, and Myf6 -Recombinant MyoD and E47 were expressed in E. coli SG13009[pREP4] containing pQT-MyoD or pQT-E47, kindly provided by Stephan F. Konieczny. Expression plasmids of pET-Myf6 and pGST-Myf4 were prepared by inserting Myf6 or Myf4 cDNA into BamHI/HindIII sites of pET-21a (Novagene) or EcoRI/XhoI sites of pGEX4T3 (Amersham Pharmacia Biotech), respectively. Myf6 and GST-Myf4 were prepared in E. coli BL21(DE3) and E. coli DH5␣, respectively. The bacteria freshly transformed with each expression vector were grown to mid-log phase and proteins were induced for 4 h with 1 mM isopropyl-1-thio-␤-D-galactopyranoside. The bacteria were harvested by centrifugation and disrupted by sonication. The recombinant proteins containing histidinetag were purified to homogeneity by Ni-NTA-agarose (Qiagen) chromatography. GST-Myf4 was purified by glutathione-Sepharose 4B (Amersham Pharmacia Biotech) chromatography according to the protocol provided by the manufacturer. The purity and the concentration of the recombinant proteins were verified by SDS-polyacrylamide gel electrophoresis followed by Coomassie Brilliant Blue staining.
Electrophoretic Mobility Shift Assay-The EMSA probes used are as follows (sequence of sense oligomers are presented here); E1 (Ϫ418/ Ϫ394), 5Ј-CCCTTGGAACATCTGTCGATGCTG-3Ј; E2 (Ϫ435/Ϫ412), 5Ј-GGCGTCTGACAGATGAACCCCTTG-3Ј; E3 (Ϫ512/Ϫ489), 5Ј-CTGTG-TGTCCAGCTGGCCATTCGT-3Ј; Pr1 (Ϫ43/Ϫ15) 5Ј-CAGCCTCCCGCT-GAAAGGTGACACTCTGCC-3Ј; Pr2 (Ϫ33/Ϫ15), 5Ј-CTGAAAGGTGAC-ACTCTGCC-3Ј; Pr3 (Ϫ24/ϩ4), 5Ј-GACACTCTGCCAGCTGGGTTCCC-TTAGT-3Ј; Pr4 (Ϫ10/ϩ10), 5Ј-TGGGTTCCCTTAGTCACCCT-3Ј; Pr5 (ϩ4/ϩ29), 5Ј-TCACCCTGTGGGCGCCTGTCAGCCTC-3Ј. Pr5 mutants used for competition assay are shown at Fig. 7A .
Each sense oligonucleotide was labeled with polynucleotide kinase (Takara) using [␥- 32 P]ATP as substrate and annealed with 5-fold excess of its complementary, unlabeled oligonucleotide by heating at 90°C for 5 min and allowing it to slowly cool to room temperature in 0.1 M Tris (pH 8.0), 50 mM NaCl. The annealed probe was purified by spun column chromatography and probes of 100,000 cpm were used for each reaction. Recombinant MyoD, GST-Myf4, Myf6, or MyoD/E47 heterodimer were incubated with the prepared probes in a final volume of 20 l containing 10 mM HEPES (pH 7.9), 75 mM KCl, 1 mM EDTA, 5 mM dithiothreitol, 5 mM MgCl 2 , 10% glycerol, 1 g of poly(dI-dC) (Amersham Pharmacia Biotech), and 0.5% fetal calf serum. After 20 min incubation at room temperature, samples were subjected to electrophoresis on 5% polyacrylamide gel in 1 ϫ TBE (45 mM Tris, 45 mM boric acid, 1 mM EDTA) at 250 V for ϳ1 h at room temperature. For the competition assays, competitors prepared by annealing the unlabeled sense and antisense oligonucleotides were added at ϳ50 -200-fold molar excess for each competition assay.
RESULTS
Cloning of Human ACC␤ Promoter-Two ACC␤ cDNA clones containing different 5Ј-UTRs of 300 and 42 bp, respectively, were previously isolated from a human skeletal muscle cDNA library (7) . A sense primer based on the 300-bp 5Ј-UTR and an antisense primer based on the 42-bp 5Ј-UTR were used to amplify a 14.5-kb product. To clone the upstream sequence of the 300-bp 5Ј-UTR, inverse PCR was performed using circular genomic DNA self-ligated after EcoRI digestion as template. The resulting 3.5-kb DNA fragment contained 2.3-kb upstream and 1.2-kb downstream sequences of the 300-bp 5Ј-UTR. The cloning strategy used to obtain the 17-kb 5Ј-flanking sequence and its restriction map are shown in Fig. 1A . The regions of 300-and 42-bp 5Ј-UTRs were named as exon 1a and exon 1b, respectively, and their 5Ј-flanking sequences were designated as PI␤ and PII␤.
To determine the transcription initiation site of ACC␤, a 32 P-labeled primer complementary to the region ϩ37 to ϩ56 The Regulation of ACC␤ Promoter by MRFsfrom the ATG codon of ACC␤ cDNA was extended using human skeletal muscle poly(A) ϩ RNA as template. The products were analyzed on a sequencing gel and a single 132-bp fragment was observed (Fig. 1B, a) . Because the primer-extension gave only one product smaller than the 300-bp 5Ј-UTR, we performed PCRs to confirm whether it contained the sequence of the 42-bp 5Ј-UTR. The 132-bp fragment was isolated from the sequencing gel slice and used as a template, and two 5Ј sense primers corresponding to the 42-bp 5Ј-UTR and one common 3Ј antisense primer of the previous primer extension, were used. Those primers amplified two PCR products of our expecting sizes, 111 bp (Ϫ55/ϩ56) and 128 bp (Ϫ72/ϩ56), respectively. This result suggests that the ACC␤ mRNA in muscle originates from PII␤ (Fig. 1B, b) . The first transcribed nucleotide of PII␤, determined by the primer extension, was designated as ϩ1 for numbering the nucleotides in the ACC␤ gene.
We tested the promoter activities of the 5Ј-flanking fragments of those two 5Ј-UTRs. The PII␤ region from Ϫ1317 to ϩ65 showed high promoter activity in H9C2 myoblast cells, while the 2.3-kb PI␤ region upstream of the 300-bp 5Ј-UTR did not have transcription activity at all in various cell lines. Computer-based analysis (MatInspector V2.2 based on Transfac 4.0) of PII␤ revealed several transcription factor-binding sites including multiple E-boxes (Fig. 2) . Therefore, in this study we investigated the cis-elements and trans-acting factors involved in the transcription regulation of PII␤ promoter.
ACC␤ Promoter Was Highly Active in Myoblast Cells and Was Strongly Activated by MyoD-According to previous reports of the tissue-specific expression of ACC␤ (6, 7, 26) , we tested the promoter activity of the Ϫ1317 to ϩ65 fragment in various cell lines. A transiently transfected luciferase reporter construct (pPII␤-1317) showed the highest promoter activity in H9C2, a rat cardiomyoblast cell line. However, its promoter activity was very low or hardly detectable in Alexander, a human hepatoma cell line, in HeLa, a human cervical carcinoma cell line, or in NIH3T3, a mouse embryonic fibroblast cell line (Fig. 3A) . The extremely low activity of pPII␤Ϫ1317 in Alexander cells was rather intriguing, because ACC␤ expression has been observed in human liver and HepG2, another human hepatoma cell line (6, 26) . The inactiveness of this promoter in Alexander cells suggested that liver might employ another promoter for ACC␤ expression. To explore whether a different promoter from PII␤ drives ACC␤ expression in liver, we examined if the ACC␤ mRNA in liver cell lines has different 5Ј-UTR from that of muscle tissue. We prepared cDNAs from total RNA of Alexander cells, and HepG2 cells, and human skeletal muscle tissue to perform RT-PCR. Only the muscle cDNA generated the 128-bp PCR product containing 5Ј-UTR (exon 1b) sequences, while those three cDNAs produced a 1-kb product for the C terminus coding region (Fig. 3B) . Both muscle and liver definitely express the ACC␤ mRNAs but the mRNAs in those two tissues have different 5Ј-UTRs. These results strongly imply the presence of liver-type ACC␤ promoter, and we concluded that PII␤ is the muscle-type ACC␤ promoter.
The multiple E-boxes picked up by the computer-based analysis suggested MRFs might act on the PII␤ (Fig. 2) . Overexpression of MyoD, a typical MRF, indeed activated the transiently transfected ACC␤ promoter effectively in every cell line except in HeLa cells (Fig. 3A) . Its relative activation by MyoD in H9C2 cells is lower than in NIH3T3 cells or Alexander cells due to high basal transcription activity in H9C2 cells, probably caused by the endogenous myogenic transcription factors. We therefore used NIH3T3 cells for further experiments instead of myoblast cells to exclude the effect of endogenous MyoD and other muscle related factors.
To identify the MyoD-responsive regions in this promoter, we constructed a group of deletion reporters containing the PII␤ promoter serially deleted from the 5Ј or 3Ј end of the Ϫ1317 to ϩ65 fragment (Fig. 4) . The deletion of Ϫ569 to Ϫ349 and Ϫ38 to Ϫ19, among the 5Ј deletion constructs, most drastically decreased the MyoD responsiveness. Deletion of the 220 bp from Ϫ569 to Ϫ349, containing a cluster of three E-boxes, decreased the MyoD responsiveness by about 50%. The reduced responsiveness was recovered in further deletions up to Ϫ39, suggesting the presence of inhibitory elements for MyoD responsiveness in the region from Ϫ340 to Ϫ39. The deletion from Ϫ93 to Ϫ39, where Sp1 can bind, most outstandingly enhanced the MyoD responsiveness. Although we cannot reveal the prescise mechanisms involved in this inhibitory action in the present study, the Sp1-binding site in this inhibitory region is considered to be noteworthy since Sp1 expression markedly decreases during myogenesis (36, 37) . Deletion from Ϫ38 to Ϫ19 resulted in a significant decrease in basal transcription as well as the decrease in MyoD responsiveness, and the further deletion to ϩ7 completely abolished MyoD responsiveness of PII␤. Deletions of the 5Ј-UTR from pPII␤Ϫ1317 also significantly diminished the MyoD responsiveness and the basal transcription level. The regions of Ϫ569 to Ϫ349 and Ϫ39 to ϩ65, which play important roles in MyoD responsiveness and/or basal transcription, are hence designated as regions A and B, respectively (Fig. 4) . (21) . Although MyoD/MyoD homodimers can bind to E-boxes in vitro, the MyoD/E-protein heterodimers recognize E-boxes on DNA strands in vivo (26, 27) . There exist three E-boxes in the Ϫ569 to Ϫ349 region designated as E-box 1, E-box 2, and E-box 3 (Fig. 5A ). E-box 1 and 2 are juxtaposed with intervening 12 nucleotides, and E-box 3 is located about 60 bp upstream from E-box 2. Interestingly, strikingly similar distributions of three E-boxes are found in various muscle-specific promoters and enhancers, such as the myosin light chain enhancer, muscle creatine kinase promoter, and acetylcholine receptor ␣ and ␦ subunit enhancers (26) . We presumed the cluster of three E-boxes on the ACC␤ promoter might contribute to its MyoD responsiveness and examined their role in MyoD responsiveness by introducing a site-specific mutation (TG 3 AA) in each (Fig. 5B) . Each single E-box mutation such as M(E1), M(E2), and M(E3) reduced the MyoD responsiveness to different extents. Mutation on E-box 1 most significantly decreased the responsiveness. Interestingly, the influences of the E-box destructions were neither synergistic nor additive. Double mutant (M(E1ϩ2)) or triple mutant (M(E1ϩ2ϩ3)) showed a similar extent of MyoD responsiveness to that of the single mutant M(E1). To confirm the MyoD binding to these E-boxes in vitro, we performed EMSA with recombinant MyoD and recombinant E47 (Fig. 5, C and D) . The probe containing E-box 1 (E1) was well shifted by MyoD, E47, or the mixture of MyoD and E47 (MyoD/E47). The probes containing E-box 2 (E2) or E-box 3 (E3) were not effectively bound by MyoD, but were shifted by E47 or MyoD/E47. All three probes were bound by MyoD/E47, even though the intensity of their shifted bands was significantly different from one another, E1 showed the strongest band shift, E3 the next, and E2 the weakest. To determine whether the differences result from differences in their binding affinity, we performed competition assays (Fig. 5E) . The complex formation between E1 and MyoD/E47 was effectively competed by cold E1, the self-competitor, moderately by cold E3, and slightly by excess amount of cold E2. Thus, E-box 1 has the strongest affinity to MyoD/E47 among the three E-boxes in region A.
MyoD Acts on the E-boxes Located in Region A-MyoD functions as a heterodimer with E-proteins such as E12 and E47

Region B Has Multiple cis-Elements Crucial for Basal Transcription and MyoD
Responsiveness-To investigate the ciselements for the MyoD responsiveness located around Ϫ38 to ϩ65 (region B), we first introduced a mutation on the single E-box (Ϫ14 to Ϫ9), designated as E-box 4, of pPII␤Ϫ93 (Fig.  6A) . The mutation of TG to AA (M(E4)) in E-box 4 reduced the MyoD responsiveness of pPII␤Ϫ93 by about 50% (Fig. 6B) . (lanes 3, 6, and 9 ). E, competition assays. The E1 band shifted by MyoD/E47 (150 ng/15 ng) was competed by 50 -200-fold molar excess amount of unlabeled competitors, such as E1 (lanes 2-4), E2 (lanes 8 -10), and E3 (lanes 5-7) .
Because the destruction of the sole E-box in pPII␤Ϫ93 did not abolish its entire MyoD responsiveness, we presumed there might exist other important sites for MyoD action in this short region, and prepared several mutant reporters to identify those motifs. We substituted the first and second TG sequences with AA, and designated the resulting mutants as M(Ϫ32) and M(Ϫ25) according to their locations. Mutation of the Ϫ32/Ϫ31 TG drastically decreased the MyoD responsiveness and the basal transcription by 74 and 50%, respectively, whereas mutation of the Ϫ25/Ϫ24 TG showed no significant change on the basal promoter activity and the stimulation by MyoD (Fig. 6, A  and B) . The TGAAA sequence from Ϫ32 to Ϫ28 appears to play a role of TATA box in the PII␤ promoter because it is located in the typical TATA box position and its mutation significantly affects the basal transcription. Next, the transcription start site (CCTT ϩ1 AG) and a palindromic hexanucleotide (GGCGCC) located at ϩ14 to ϩ19 were substituted with AAGCTT. Those mutants, designated as M(start) and M(GC), showed remarkably decreased MyoD responsiveness by 89 and 85%, respectively. M(start) also showed significantly decreased basal transcription by over 80% while M(GC) did not show decrease in basal transcription, suggesting that the transcription start region might serve as an Inr element. To discern the cis-elements for MyoD from those for the general transcription complex, we examined where MyoD can bind in this region by EMSA using the probes shown in Fig. 6A . Probe Pr3 containing E-box 4 and probe Pr5 containing the GGCGCC palindrome could form a complex with recombinant MyoD, whereas the other probes could not (Fig. 6C) .
Probe Pr5 (ϩ4/ϩ29) Is Preferentially Bound by MyoD/MyoD Homodimer-The transient transfection assay of the M(GC) mutant and the EMSA with Pr5 (Fig. 6) indicate the presence of a MyoD-responsive element, that is not a canonical E-box, in the region around ϩ4 to ϩ29. To clarify the precise core sequence for MyoD-binding, competitive EMSA was performed using mutant Pr5 oligonucleotides harboring substitutions (Fig. 7A) . Competitors containing mutations from ϩ17 to ϩ24 could not compete effectively against Pr5, suggesting that the sequence of GCCTGTCA (ϩ17 to ϩ24) is important for MyoD binding.
From the previous EMSA (Fig. 6C) , MyoD seems to bind to this element more avidly than to E-box 4. We compared this novel cis-element with the E-box in vitro by EMSA. As shown at Fig. 7B , E47 had strong affinity to Pr3 (lanes 1 and 2) and very poor affinity to Pr5 (lane 7 and 8), while MyoD showed much higher affinity to Pr5 than to Pr3 (lanes 3, 4, 9, and 10) . Heterodimerization of E47 and MyoD did not affect the high affinity of E47 to Pr3 (lanes 5 and 6), while it did significantly decrease complex formation to Pr5 in comparison with MyoD homodimer (lane 11 and 12) . These results suggested that the novel cis-element in Pr5 prefers the MyoD homodimer to E47 homodimer or MyoD/E47 heterodimer. Moreover, these results corresponded to the in vivo results of transient transfection assays using artificial promoter-reporter constructs, which contained the E-box clustering region of PII␤ (Ϫ569 to Ϫ204) (pE-box-tk-luc) or six copies of ϩ8 to ϩ27 sequence (p6ϫ(ϩ8/ ϩ27)-tk-luc) upstream of tk minimal promoter (Fig. 7C) . The tk minimal promoter itself was not affected by overexpression of E12 or MyoD. E12 alone did not stimulate pE-box-tk-luc or p6ϫ(ϩ8/ϩ27)-tk-luc, while MyoD-overexpression enhanced the transcription of both reporter constructs. Coexpression of E12 with MyoD synergistically activated the transcription in pEbox-tk-luc compared with the transcription driven by MyoD alone. However, coexpression of E12 significantly decreased the transcription of p6ϫ(ϩ8/ϩ27))-tk-luc stimulated by MyoD. Taken together, this novel cis-element is more apt to respond to the MyoD homodimer rather than to the E-protein/MyoD heterodimers and therefore is distinct from E-boxes.
MRFs Bind to the Novel cis-Element in Vivo-To isolate the trans-acting factors acting on region B, we screened a human skeletal muscle cDNA library using the yeast one-hybrid system. Three bait constructs were generated by insertion of three copies of the nucleotide sequence corresponding to the regions of Ϫ42 to Ϫ23, Ϫ10 to ϩ10, and ϩ8 to ϩ27 upstream of the HIS3 gene. We isolated the clones expressing the GAL4 activation domain fused to DNA-binding proteins, which bind to the bait sequences, and thus activate the HIS3 gene expression allowing selection in histidine-depleted media. We could not obtain any positive clones as for the Ϫ42 to Ϫ23 or Ϫ10 to ϩ10 regions, while several positive clones were isolated for the ϩ8 to ϩ27 region. Sequencing of those isolated clones revealed that one of them contained the full-length Myf4 cDNA and the other seven clones contained various lengths of Myf6 cDNA. These data suggest that MRFs bind to the ϩ8 to ϩ27 region in vivo, where the E-box consensus sequence does not exist. To confirm their binding ability to this DNA sequence in vitro by EMSA, we prepared recombinant Myf4, Myf6, and MyoD expressed in bacteria (Fig. 8B) . MyoD, Myf4, and Myf6 could bind to this region in vitro. Those bindings were effectively competed by a 200-fold molar excess of the unlabeled wild type Pr5 (Fig. 8A,  lanes 3, 6, and 9) , while the addition of excess cold mPr5.4, an oligonucleotide containing GGCGCC 3 AAGCTT mutation, did not decrease complex formation (Fig. 8A, lanes 4, 7, and 10) .
We tested whether MyoD and Myfs induce transcriptional activation on the promoters containing this novel cis-element. pPII␤Ϫ93 and p6ϫ(ϩ8/ϩ27)-tk-luc were greatly activated by MyoD or Myf6, while tk promoter itself was not activated by MyoD or Myf6 (Fig. 8C) . All together these in vivo and in vitro data, we conclude that the GCCTGTCA motif truly is a novel cis-element for MRF transcription factors. 2 and 7, 8) , 100 or 200 ng of MyoD (lanes 3, 4 and 9, 10), and 50/25 or 100/50 ng of the MyoD/E47 mixture (lanes 5, 6 and 11, 12) . C, comparison of the E-box 4 and the novel cis-element in vivo. The E-box clustered region (Ϫ569 to Ϫ204) or 6 copies of the ϩ8 to ϩ27 sequence were inserted upstream of the minimal tk promoter of ptk-luc construct as described under "Materials and Methods." Each reporter (0.4 g) with pCMV ␤-galactosidase (0. 
DISCUSSION
In this study, we have introduced the muscle-type promoter of ACC␤ and characterized the cis-elements and trans-acting factors related. Moreover, we are suggesting the presence of the liver-type ACC␤ promoter. The PII␤ promoter in the present study was cloned according to the information of 5Ј-UTR sequence of ACC␤ cDNA originating the from skeletal muscle. However, because ACC␤ is expressed not only in skeletal muscle but also in liver, another promoter different from the PII␤ seems to induce the ACC␤ expression in liver. The following evidence supports this suggestion. First, the PII␤ promoter was highly active in myoblast but not in the hepatoma cell line. Second, the sequences of exon 1b transcribed by the PII␤ exists only in the ACC␤ mRNA of skeletal muscle and not in that of hepatoma cell lines such as Alexander and HepG2, while the sequences for the C terminus region of ACC␤ could be detected in both mRNAs from skeletal muscle and hepatoma cell lines. Conclusively, ACC␤ expression might employ another promoter in liver, and the PII␤ is its muscle-specific promoter.
The trans-acting factors involved in the PII␤ promoter are identified as MRF family members, such as MyoD, myogenine/ Myf4, and MRF4/Myf6. The myogenic regulatory factor-mediated transcription in this promoter depends on four E-boxes and one novel cis-element immediately downstream from the transcription start site, and at least two cis-elements which are not fully characterized but appear to be important for basal transcription. Among the four E-boxes, three of them were located in a distal region (Ϫ498 to Ϫ403), and one resides in a very proximal region (Ϫ14 to Ϫ9). The distal E-box clustered region (region A) is responsible for up to 50% of the MyoD responsiveness of this promoter, and the proximal region (region B), harboring the fourth E-box and a novel downstream cis-element, is responsible for the other 50% of MyoD responsiveness. E-box 1 of the clustered three E-boxes is thought to be most critical for the MyoD responsiveness of region A, although E-boxes 2 and 3 are also required for full activity. This distribution of triple E-boxes and the finding that, while all are necessary, one of the three is more crucial, has been reported by Wentworth et al. (26) in the myosin light chain enhancer. In addition, the E-box 1 (caTCtg) has never been reported as an MRF-binding site as far we know, while E-box 3, the less critical MyoD responsive site (caGCtg) has been repeatedly reported as a binding motif for MyoD/E-protein heterodimers in several muscle gene promoters (29, 30) . E-box 2 (caGAtg) is reported to exist in the promoter of mouse acetylcholine receptor ␣ subunit (35) , but its weak binding affinity for MyoD/E47 do not allow ignoring the possibility that other transcription factors bind to this region and help the action of neighboring MyoD.
Between regions A and B (Ϫ349 to Ϫ39), unidentified repressor elements that might control the MyoD responsiveness seem to exist, because the deletion of this region enhanced the MyoD responsiveness. The enhancement was most prominent when the region containing an Sp1-binding site was excised out. According to our unpublished EMSA data 2 using the nuclear extracts of the H9C2 myoblasts and its differentiated myotubes, Sp1 binding to the consensus motif (Ϫ70 to Ϫ65) is severely decreased in muotubes. This result corresponds to the fact that myogenesis accompanies Sp1 decrease (36, 37) . The Sp1 binding to this region might suppress the MyoD responsiveness in myoblasts and down-regulation of Sp1 during differentiation to myotube would be required for complete activation of the ACC␤ gene by MyoD.
In region B, the proximal MyoD-responsive region, a well conserved E-box 4 (caGCtg) and a novel cis-element containing a GCCTGTCA sequence (Fig. 7) were identified as responsible for the MyoD responsiveness. This novel MyoD-binding site is very different from E-boxes where MRF binding is mediated by dimerization with E-proteins. The presence of E47 weakened the MyoD binding to this element in vitro, and coexpression of E12 diminished the MyoD-mediated stimulation on p6ϫ(ϩ8/ ϩ27)-tk-luc in vivo (Fig. 7) . Those inhibitory effects of E-proteins seem to result from the dimerization of MyoD with E-proteins. In other words, MyoD binding to this site is not mediated by heterodimerization with E-proteins such as E47 and E12. This novel sequence, which was avidly bound by homodimeric MyoD, seems to be bound by other MRF family factors. Using the yeast one-hybrid system, we found that other myogenic transcription factors such as Myf4 and Myf6 are recruited by this novel cis-element. They all are bHLH proteins, responsible for muscle differentiation, bind to E-boxes, and heterodimerize with E-proteins (23, 28 -32) . Interaction of these Myfs with this site was successfully demonstrated in vitro and in vivo by EMSA and transient transfection assays (Fig. 8) . Taken together, the novel cis-clement containing GCCTGTCA sequence functions as a general binding site for bHLH myogenic transcription factors without E-protein mediation.
Region B is a very proximal regulatory region and is thus, thought to contain basic elements responsible for the initiation of transcription through interactions with RNA polymerase II -7) , or Myf6 (lanes 8 -10) . Both wild type (lanes 3, 6, and 9) and mutant (mPr5.4) unlabeled double-stranded oligonucleotides (lanes 4, 7, and 10) were used as competitors. B, SDS-PAGE showing the purified recombinant proteins used in the EMSA. Lanes 1-4, the molecular weight size markers (Genepia, Korea), MyoD, GST-Myf4, and Myf6, respectively. C, the reporter constructs (0.4 g each), such as ptk-luc, p6ϫ(ϩ8/ϩ27)-tk-luc, and pPII␤Ϫ93, were transfected into NIH3T3 cells with pcMyoD, pcMyf6, or pcDNA3 (0.4 g each), and pCMV ␤-galactosidase (0.2 g) was co-transfected. Fold increase of the MyoD-or Myf6-mediated induction compared with the basal activity of each reporter is shown above the bars. The reporter activities are shown as the relative luciferase activity normalized by the ␤-galactosidase activity. The data represents the means Ϯ S.D. of five independent experiments performed in triplicate.
and general initiator factors. The TGAAA at Ϫ32 region appears to play a role similar to a "TATA" element since it is located at the general TATA locus and the mutation at this region dramatically reduced the basal transcription. The previously reported consensus Inr sequence (YYA ϩ1 N(T/A)YY) of metazoan (33, 34 ) is similar to the start region (CTT ϩ1 AGTC) of this ACC␤ promoter and disruption of this site decreased the basal transcription significantly. These findings suggest that this region might function as the Inr element of basal transcription.
A previous study reported that ACC␤ expression is not observed in myoblast cells which express high levels of MRFs and is observed only after the differentiation of myoblast cells into myotubes (7) . However, the promoter activity of ACC␤ was very high in H9C2 myoblasts in our transient transfection assay (Fig. 3) . According to our unpublished data, 2 the ACC␤ promoter, stably transfected into H9C2 myoblast cells, shows very high basal activity and was not further enhanced by differentiation into myotubes (data not shown). These discrepancies between transfection assays and endogenous gene expression suggest that MRFs are required for maintnaining high level expression of ACC in muscle cells, and another switching system exist to turn on the expression of this muscle-specific gene. Further studies on the switching system might provide a general understanding for stage-specific turning on and off of muscle-specific genes. We now introduce the first report on the regulation mechanism for the muscle-type ACC␤ promoter and also suggest the possible presence of the liver-type ACC␤ promoter.
